BioXcel Therapeutics, Inc. – Filings and Transcripts

OTC: BTAIQ
Share price (11/5/26): $0.01
Market cap (11/5/26): $275 thousand

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Armistice Capital, LLC

Atkins Susan E.

Atkins Susan E.

Rodriguez Javier

Steinhart Richard I

News Filter

Order (A) Approving the Sale of the Debtors’ Assets Free and Clear of Liens, Claims, Interests, and Encumbrances, (B) Approving the Assumption and Assignment of Executory Contracts and Unexpired Leases, and (C) Granting Related Relief

New Financial Obligation or Off-Balance Sheet Arrangement, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Material Definitive Agreement, Bankruptcy or Receivership

Material Definitive Agreement, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness